Parker Waichman LLP Announces Investigation into Multiple Sclerosis Drug That Can Cause Stroke or Death
Nationally renowned drug-defect attorneys Parker Waichman LLP announce that their firm has opened an investigation into the Multiple Sclerosis (MS) drug Lemtrada (alemtuzumab) and its potential to cause the MS patient to suffer a stroke which could kill the patient. The U.S. Food and Drug Administration (FDA) issued an urgent warning on November 29, 2018, alerting patients about the possible lethal side effects of taking Lemtrada. The FDA said that the potential side effects are rare but could lead to permanent disability or death. As a consequence of this warning, the FDA mandated that the manufacturer of Lemtrada, Genzyme and its parent company Sanofi, change the drug’s “box warning” and include within it information about the potential for stroke.
Parker Waichman LLP’s high-regarded and well-respected drug defect lawyers vow to vigorously and relentlessly pursue drug companies like Genzyme and Sanofi for harming innocent people who rely on medications to live. If you have relapsing-remitting MS and takes Lemtrada, Campath, or another brand name for the drug alemtuzumab, and have suffered a stroke or other side effects, contact Parker Waichman LLP as soon as possible to protect your rights. A patient injured or killed from taking Lemtrada and his or her family may be eligible to receive a substantial economic settlement.
Warning Signs of a Stroke After Taking Lemtrada
Lemtrada is drug physician administer intravenous via transfusion. It is a very powerful drug that MS patients who have relapsing-remitting MS take to control their symptoms when other drugs fail. As such, Lemtrada is a desperate attempt to salvage his or her life. Many MS patients have experienced significant benefits from taking Lemtrada. However, several people have suffered life-threatening side effects including strokes.
MS patients and their caregivers must be aware of the symptoms of a stroke such as:
- numbness or weakness focused on one side of the body,
- rapid onset of confusion, inability to speak, or inability to understand language,
- vision problems in one or both eyes,
- trouble walking,
- difficulty maintaining balance and coordination,
- a headache and neck pain.
The MS patient must receive immediate emergency medical treatment for a stroke if any of these symptoms appear, especially if they within one to three days after receiving a Lemtrada infusion. Failure to take quick action can result in permanent disability or death.
What Causes a Stroke after Taking Lemtrada?
A Lemtrada infusion can tear the lining of the blood vessels in the head and neck. Tears in blood vessels, also known as arterial dissections, stop the flow of oxygenated blood to the brain, thereby causing a stroke. Brain cells cannot live without oxygenated blood after the flow of oxygenated blood to the brain ceases for longer than a few minutes. The risk of injury or death increases with each passing minute that oxygenated blood does not reach the brain.
The FDA is only aware of thirteen cases when a person suffered a stroke after taking Lemtrada. One of those patients died. In all but one case, the symptoms of stroke occurred within one day of the Lemtrada infusion. The MS patient in the last case suffered a stroke within three days of his or her infusion. The FDA admits that they only know about those instances of a stroke suffered by MS patients which physicians report to the FDA. Therefore, the instances of stroke might be much greater than reported.
Parker Waichman LLP: Fighting for MS Patients Injured by Major Medical Manufacturers
Parker Waichman LLP’s Lemtrada Side Effect Lawyers have your best interest at heart. They will aggressively fight on your behalf and on behalf of your family, so you can receive the compensation that you deserve. Call 1-800-YOURLAWYER today to initiate your claim.
Have you or a loved one suffered a stroke while taking Lemtrada?Click To Get A Free Case Review